WO2009008412A1 - 放射線治療後における泌尿器の晩期有害反応の発症予測用dnaチップ、及びこれを用いた放射線治療後における泌尿器の晩期有害反応の発症予測方法 - Google Patents
放射線治療後における泌尿器の晩期有害反応の発症予測用dnaチップ、及びこれを用いた放射線治療後における泌尿器の晩期有害反応の発症予測方法 Download PDFInfo
- Publication number
- WO2009008412A1 WO2009008412A1 PCT/JP2008/062297 JP2008062297W WO2009008412A1 WO 2009008412 A1 WO2009008412 A1 WO 2009008412A1 JP 2008062297 W JP2008062297 W JP 2008062297W WO 2009008412 A1 WO2009008412 A1 WO 2009008412A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- adverse reaction
- radiation therapy
- urinary organ
- occurrence
- prediction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/452,500 US20100130376A1 (en) | 2007-07-06 | 2008-07-07 | Dna chip for prediction of occurrence of late adverse reaction in urinary organ after radiotherapy, and method for prediction of occurrence of late adverse reaction in urinary organ after radio therapy using the same |
JP2009522644A JP4974091B2 (ja) | 2007-07-06 | 2008-07-07 | 放射線治療後における泌尿器の晩期有害反応の発症予測用dnaチップ、及びこれを用いた放射線治療後における泌尿器の晩期有害反応の発症予測方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92966207P | 2007-07-06 | 2007-07-06 | |
US60/929,662 | 2007-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009008412A1 true WO2009008412A1 (ja) | 2009-01-15 |
Family
ID=40228582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/062297 WO2009008412A1 (ja) | 2007-07-06 | 2008-07-07 | 放射線治療後における泌尿器の晩期有害反応の発症予測用dnaチップ、及びこれを用いた放射線治療後における泌尿器の晩期有害反応の発症予測方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20100130376A1 (ja) |
JP (1) | JP4974091B2 (ja) |
WO (1) | WO2009008412A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015128435A (ja) * | 2009-10-19 | 2015-07-16 | ロスタクオ・ソシエタ・ペル・アチオニROSTAQUO S.p.A. | 心血管状態の薬理ゲノミクス治療のための方法およびシステム |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007116905A (ja) * | 2005-10-24 | 2007-05-17 | Natl Inst Of Radiological Sciences | 放射線治療における副作用発症予測用ポリヌクレオチドおよび放射線治療における副作用発症予測方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US20020028455A1 (en) * | 2000-05-03 | 2002-03-07 | Laibinis Paul E. | Methods and reagents for assembling molecules on solid supports |
US20040210400A1 (en) * | 2003-01-27 | 2004-10-21 | Perlegen Sciences, Inc. | Analysis methods for individual genotyping |
-
2008
- 2008-07-07 JP JP2009522644A patent/JP4974091B2/ja active Active
- 2008-07-07 WO PCT/JP2008/062297 patent/WO2009008412A1/ja active Application Filing
- 2008-07-07 US US12/452,500 patent/US20100130376A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007116905A (ja) * | 2005-10-24 | 2007-05-17 | Natl Inst Of Radiological Sciences | 放射線治療における副作用発症予測用ポリヌクレオチドおよび放射線治療における副作用発症予測方法 |
Non-Patent Citations (4)
Title |
---|
APOSTOLOPOULOS J. ET AL.: "Identification and characterization of a novel family of mammalian ependymin-related proteins (MERPs) in hematopoietic, nonhematopoietic, and malignant tissues", DNA CELL BIOL., vol. 20, 2001, pages 625 - 635 * |
IMAI T.: "Idenshi Tagata Marker o Mochiita Hoshasen Chiryogo Yugai Hanno Yosokuho", NIRS-M, vol. 182, 2005, pages 81 - 93 * |
ISHIKAWA K. ET AL.: "Gene expression profile changes correlating with radioresistance in human cell lines", INT. J. RADIAT. ONCOL. BIOL. PHYS., vol. 65, 2006, pages 234 - 245 * |
NODA S. ET AL.: "Zenritsusengan Hoshasen Chiryogo , Hinyokikei Yugai Jisho Hassho ni Kanren shita Idenshi Marker no Kensaku", THE JAPANESE CANCER ASSOCIATION GAKUJUTSU SOKAI KIJI, vol. 64, 2005, pages 262 - 263 + ABSTR. NO. W-453 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015128435A (ja) * | 2009-10-19 | 2015-07-16 | ロスタクオ・ソシエタ・ペル・アチオニROSTAQUO S.p.A. | 心血管状態の薬理ゲノミクス治療のための方法およびシステム |
Also Published As
Publication number | Publication date |
---|---|
US20100130376A1 (en) | 2010-05-27 |
JPWO2009008412A1 (ja) | 2010-09-09 |
JP4974091B2 (ja) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jagomägi et al. | MTHFR and MSX1 contribute to the risk of nonsyndromic cleft lip/palate | |
CA2591840A1 (en) | Genetic variants predicting warfarin sensitivity | |
Laffita-Mesa et al. | Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications | |
JP2010507388A5 (ja) | ||
NZ589863A (en) | Genetic markers for weight management and methods of use thereof | |
JP2012503985A5 (ja) | ||
NZ590893A (en) | Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment | |
JP2011520433A5 (ja) | ||
Atanasova et al. | Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN) | |
JP2010520745A5 (ja) | ||
JP2014506459A5 (ja) | ||
NZ701432A (en) | Improved method and kit for determining severity and progression of periodontal disease | |
WO2008132763A3 (en) | Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction | |
WO2010103292A3 (en) | A genotyping tool for improving the prognostic and clinical management of ms patients | |
WO2012031207A3 (en) | Methods and compositions for correlating genetic markers with prostate cancer risk | |
Lopes et al. | Clustered transcripts that escape X inactivation at mouse XqD | |
Neves et al. | A high-density transcript linkage map with 1,845 expressed genes positioned by microarray-based Single Feature Polymorphisms (SFP) in Eucalyptus | |
WO2009097270A3 (en) | Method of determining breast cancer risk | |
JP2008539782A5 (ja) | ||
EP3075865A3 (en) | Genetic markers for efficacy of iloperidone in the treatment of psychotic symptoms | |
US9944987B2 (en) | Assessment of risk of aneuploidy | |
Makridakis et al. | Identification and characterization of somatic steroid 5α-reductase (SRD5A2) mutations in human prostate cancer tissue | |
WO2005112568A3 (en) | Haplotype markers and methods of using the same to determine response to treatment | |
JP2007501627A5 (ja) | ||
KR102033813B1 (ko) | 항정신병약물-베이스 치료에 의하여 유발된 추체외로 증상 (eps)의 개시를 예측하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08790934 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12452500 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009522644 Country of ref document: JP |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08790934 Country of ref document: EP Kind code of ref document: A1 |